Multicenter, Randomized, Double-Blind, Placebo-Controlled Study For Moderately To Severely Active Crohn’s Disease.
You may qualify if:
- Male or female aged 18 to 75 years of age.
- Have signs and symptoms consistent with a diagnosis of CD for at least 3 months.
- Have had inadequate response or loss of response to or is intolerant of at least 1 of the following CD treatments: corticosteroids, immunomodulators, biologic therapy (eg, ustekinumab, TNFα antagonists, or vedolizumab.
- If you are a female and are not pregnant or breastfeeding.